HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard L Elford Selected Research

Infections

1/2011Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected mice.
1/2005Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
11/2002Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard L Elford Research Topics

Disease

6Neoplasms (Cancer)
02/2024 - 08/2002
5Leukemia
01/2014 - 08/2002
3Breast Neoplasms (Breast Cancer)
02/2024 - 11/2015
3Infections
01/2011 - 11/2002
3Murine Acquired Immunodeficiency Syndrome (MAIDS)
01/2005 - 11/2002
2Splenomegaly
06/2004 - 11/2002
2Hypergammaglobulinemia (Hyperimmunoglobulinemia)
06/2004 - 11/2002
1Triple Negative Breast Neoplasms
01/2021
1Left Ventricular Dysfunction
01/2021
1Heart Failure
01/2021
1Inflammation (Inflammations)
01/2020
1Hemolysis
01/2020
1Anaphylaxis (Anaphylactic Shock)
12/2017
1Atopic Dermatitis (Atopic Eczema)
09/2017
1Allergic Rhinitis
09/2017
1Asthma (Bronchial Asthma)
09/2017
1Graft vs Host Disease (Graft-Versus-Host Disease)
08/2010
1Atherosclerosis
12/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2009
1Vascular Remodeling
07/2005
1Medulloblastoma
08/2004
1Gliosarcoma
08/2004
1Virus Diseases (Viral Diseases)
06/2004
1Disease Progression
11/2002
1Retroviridae Infections (Infection, Retrovirus)
11/2002
1Prostatic Neoplasms (Prostate Cancer)
09/2002

Drug/Important Bio-Agent (IBA)

13Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
02/2024 - 08/2002
123,4-dihydroxybenzohydroxamic acidIBA
02/2024 - 09/2002
53,4,5-trihydroxybenzamidoximeIBA
02/2006 - 08/2002
3Estrogen ReceptorsIBA
02/2024 - 11/2015
3Hydroxyurea (Hydrea)FDA LinkGeneric
07/2005 - 11/2002
3AcidsIBA
06/2004 - 09/2002
2Immunoglobulin E (IgE)IBA
12/2017 - 09/2017
2EnzymesIBA
07/2005 - 08/2002
2DNA (Deoxyribonucleic Acid)IBA
06/2004 - 11/2002
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2004 - 08/2002
1Biomarkers (Surrogate Marker)IBA
02/2024
1palbociclibIBA
02/2024
1Cyclin D1IBA
02/2024
1ElementsIBA
02/2024
1Proteins (Proteins, Gene)FDA Link
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1AnthracyclinesIBA
01/2021
1AntioxidantsIBA
12/2017
1Interleukin-33IBA
09/2017
1ribonucleotide reductase M2IBA
11/2015
1TamoxifenFDA LinkGeneric
11/2015
1CytokinesIBA
01/2011
1Gallic AcidIBA
01/2007
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2006
1Cisplatin (Platino)FDA LinkGeneric
02/2006
1Antiviral Agents (Antivirals)IBA
01/2005
1Didanosine (Videx)FDA LinkGeneric
01/2005
1Carmustine (FIVB)FDA Link
08/2004
1Alkylating AgentsIBA
08/2004
1GuanineIBA
06/2004
1abacavir (Ziagen)FDA Link
06/2004
1Antineoplastic Agents (Antineoplastics)IBA
01/2004
1AmidoxIBA
01/2004
1Free RadicalsIBA
11/2002
1Radiation-Sensitizing AgentsIBA
09/2002
12'-deoxycytidine 5'-triphosphate (dCTP)IBA
08/2002

Therapy/Procedure

5Therapeutics
02/2024 - 11/2002
2Drug Therapy (Chemotherapy)
01/2004 - 08/2002
1Adjuvant Chemotherapy
01/2021
1Stem Cell Transplantation
08/2010
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2010
1Stents
12/2009